NCT06563232View on ClinicalTrials.gov

22G-Adapt Needle Biopsy Versus Fine-needle Aspiration in Endoscopic Ultrasound-guided Sampling of Solid Lesions

NANot yet recruitingINTERVENTIONAL
Enrollment

656

Participants

Timeline

Start Date

September 1, 2024

Primary Completion Date

December 1, 2025

Study Completion Date

February 1, 2026

Conditions
Pancreatic NeoplasmsMediastinal NeoplasmsAbdominal Neoplasm, Excluding Pancreas Neoplasm
Interventions
DEVICE

FNA group

Fine-needle-aspiration (22G EchoTip Ultra Echo-3-22)

DEVICE

Adapt FNB group

Fine-needle-biopsy (22G Adapt Aspiration)

Trial Locations (1)

430030

Tongji Hospital, Tongji Medical College, HUST, Wuhan

All Listed Sponsors
collaborator

Peking Union Medical College Hospital

OTHER

collaborator

Fudan University

OTHER

collaborator

Qilu Hospital of Shandong University

OTHER

collaborator

Chongqing University Cancer Hospital

OTHER

collaborator

The First Affiliated Hospital of Zhengzhou University

OTHER

lead

Huazhong University of Science and Technology

OTHER

NCT06563232 - 22G-Adapt Needle Biopsy Versus Fine-needle Aspiration in Endoscopic Ultrasound-guided Sampling of Solid Lesions | Biotech Hunter | Biotech Hunter